Ident. | Authors (with country if any) | Title |
---|
000004 (2020) |
Yu Wu ; Claire Boulogne [France] ; Stefan Carle ; Maria Podinovskaia ; Holger Barth ; Anne Spang ; Jean-Christophe Cintrat ; Daniel Gillet ; Julien Barbier | Regulation of endo-lysosomal pathway and autophagic flux by broad-spectrum anti-pathogen inhibitor ABMA |
000116 (2020) |
Xiaoyan Si ; Peng Song ; Jun Ni ; Mingyi Di ; Chunxia He ; Li Zhang ; Xiaowei Liu ; Yue Li ; Hanping Wang ; Xiaoxiao Guo ; Jiaxin Zhou ; Lian Duan ; Xu Yang ; Mengzhao Wang ; Li Zhang | Management of immune checkpoint inhibitor‐related adverse events: A review of case reports |
000184 (2020) |
Andrew C. Johns [États-Unis] ; Chad Sorenson [États-Unis] ; Alan Rogers [États-Unis] ; Julia L. Agne [États-Unis] ; Desmond M. D'Souza [États-Unis] ; Jishu K. Das [États-Unis] ; Majd Issa [États-Unis] ; Gina Perna [États-Unis] ; Terence M. Williams [États-Unis] ; Alexa Meara [États-Unis] ; Trevor Kitchin [États-Unis] ; Karl E. Haglund [États-Unis] ; Dwight H. Owen [États-Unis] | Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy. |
000279 (2019) |
Dong Liang [République populaire de Chine] ; Hong-Ying Wang [République populaire de Chine] ; Shu Fan [République populaire de Chine] ; Jin Wang [République populaire de Chine] ; Ying Shen [République populaire de Chine] ; Chen-Ying Gao [République populaire de Chine] ; Man-Li Wu [République populaire de Chine] ; She-Min Lu [République populaire de Chine] ; San-Qi Zhang [République populaire de Chine] ; Wei Han [Suède] | W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors. |
000327 (2019) |
Eun Young Kim ; Jin Gu Lee ; Jung Mo Lee ; Arum Kim ; Hee Chan Yoo ; Kibum Kim ; Minji Lee ; Chulho Lee ; Gyoonhee Han ; Jung Min Han ; Yoon Soo Chang | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
000342 (2019) |
Silvia Matteoni [Italie] ; Claudia Abbruzzese [Italie] ; Paola Matarrese [Italie] ; Gabriele De Luca [Italie] ; Anna M. Mileo [Italie] ; Stefania Miccadei [Italie] ; Silvia Schenone [Italie] ; Francesca Musumeci [Italie] ; Tobias L. Haas [Italie] ; Giovanni Sette [Italie] ; Carmine M. Carapella [Italie] ; Rosario Amato [Italie] ; Nicola Perrotti [Italie] ; Michele Signore [Italie] ; Marco G. Paggi [Italie] | The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells |
000343 (2019) |
Bo Wang [République populaire de Chine] ; Guanjun Dong [République populaire de Chine] ; Qingqiing Zhang [République populaire de Chine] ; Fenglian Yan [République populaire de Chine] ; Zhihua Li [République populaire de Chine] ; Chunxia Li [République populaire de Chine] ; Hui Zhang [République populaire de Chine] ; Qun Ma [République populaire de Chine] ; Jun Dai [République populaire de Chine] ; Chuanping Si [République populaire de Chine] ; Huabao Xiong [États-Unis] | The inhibitor of autophagy SBI-0206965 aggravates atherosclerosis through decreasing myeloid-derived suppressor cells |
000377 (2019) |
Shoko Murakami [Japon] ; Tatsuya Nagano [Japon] ; Kyosuke Nakata [Japon] ; Akira Onishi [Japon] ; Kanoko Umezawa [Japon] ; Naoko Katsurada [Japon] ; Masatsugu Yamamoto [Japon] ; Motoko Tachihara [Japon] ; Kazuyuki Kobayashi [Japon] ; Yoshihiro Nishimura [Japon] | Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review |
000383 (2019) |
Markus Lauter ; Anja Weber ; Robert Torka | Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation |
000388 (2019) |
Yuanyuan Liu ; Hong Song ; Huanqing Song ; Xiaoxia Feng ; Chuan Zhou ; Zhifang Huo | Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia |
000397 (2019) |
Chun-Han Chen [Taïwan] ; Tsung-Han Hsieh [Taïwan] ; Yu-Chen Lin [Taïwan] ; Yun-Ru Liu [Taïwan] ; Jing-Ping Liou [Taïwan] ; Yun Yen [Taïwan] | Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells |
000510 (2019) |
Ping He [République populaire de Chine] ; Yanzi Guo [République populaire de Chine] ; Junji Wang [République populaire de Chine] ; Lina Yan [République populaire de Chine] ; Aimin Feng [République populaire de Chine] | Protection of ripasudil, a Rho kinase inhibitor, in lipopolysaccharides-induced acute pneumonia in mice |
000530 (2019) |
Cassandra Calabrese [États-Unis] ; Laura C. Cappelli [États-Unis] ; Marie Kostine [France] ; Elizabeth Kirchner [États-Unis] ; Tawnie Braaten [États-Unis] ; Leonard Calabrese [États-Unis] | Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature |
000590 (2019) |
Tariq Hussain ; Deming Zhao ; Syed Zahid Ali Shah [Pakistan] ; Naveed Sabir ; Jie Wang ; Yi Liao ; Yinjuan Song ; Haodi Dong ; Mazhar Hussain Mangi ; Jiamin Ni ; Lifeng Yang ; Xiangmei Zhou | Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy |
000609 (2019) |
Toshiki Etani ; Taku Naiki ; Aya Naiki-Ito ; Takayoshi Suzuki [Japon] ; Keitaro Iida ; Satoshi Nozaki ; Hiroyuki Kato ; Yuko Nagayasu ; Shugo Suzuki ; Noriyasu Kawai ; Takahiro Yasui ; Satoru Takahashi | NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy |
000620 (2019) |
Maria Mrakovcic [Allemagne] ; Leopold F. Fröhlich | Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy |
000665 (2019) |
Mei-Chuan Chen [Taïwan] ; Yu-Chen Lin ; Yu-Hsuan Liao ; Jing-Ping Liou ; Chun-Han Chen [Taïwan] | MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells |
000717 (2019) |
Nicole Yang [États-Unis] ; Jie Huang [États-Unis] ; Michelle Frits [États-Unis] ; Christine Iannaccone [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Nader Rifai [États-Unis] ; Nancy Shadick [États-Unis] ; Gary Bradwin [États-Unis] ; Katherine P. Liao [États-Unis] | Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis |
000727 (2019) |
Yi-Sheng Liu [Taïwan] ; Yu-Chun Chang [Taïwan] ; Wei-Wen Kuo [Taïwan] ; Ming-Cheng Chen [Taïwan] ; Hsi-Hsien Hsu [Taïwan] ; Chuan-Chou Tu [Taïwan] ; Yu-Lan Yeh [Taïwan] ; Vijaya Padma Viswanadha [Inde] ; Po-Hsiang Liao [Taïwan] ; Chih-Yang Huang [Taïwan] | Inhibition of Protein Phosphatase 1 Stimulates Noncanonical ER Stress eIF2α Activation to Enhance Fisetin-induced Chemosensitivity in HDAC Inhibitor-resistant Hepatocellular Carcinoma Cells |
000735 (2019) |
Chang-Fang Chiu [Taïwan] ; Hsien-Kuo Chin [Taïwan] ; Wei-Jan Huang ; Li-Yuan Bai [Taïwan] ; Hao-Yu Huang [Taïwan] ; Jing-Ru Weng [Taïwan] | Induction of Apoptosis and Autophagy in Breast Cancer Cells by a Novel HDAC8 Inhibitor |
000758 (2019) |
Lu Zhang [République populaire de Chine] ; Pengfei Qiang [République populaire de Chine] ; Jingting Yu [République populaire de Chine] ; Yiming Miao [République populaire de Chine] ; Zhiqiang Chen [République populaire de Chine] ; Ju Qu [République populaire de Chine] ; Qianbing Zhao [République populaire de Chine] ; Zhuo Chen [République populaire de Chine] ; Yachao Liu [République populaire de Chine] ; Xin Yao [République populaire de Chine] ; Bin Liu [République populaire de Chine] ; Liuqing Cui [République populaire de Chine] ; Hongjuan Jing [République populaire de Chine] ; Gangchun Sun [République populaire de Chine] | Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer. |